All Type of News
Factive's potential value worths 244.3 billion won
As the Advisory Committee of the US FDA consisting of outside experts recommended the approval of LG Life Sciences' novel fluoroquinolone antibiotic Factive through hearings on March 4, the FDA will be likely to appro...
MOHW to revamp national pension scheme.
Minister Kim indicated in the press interview on Mar. 4 that the NHI financing system should be integrated by the end of coming June and the current low-premium but high payment structures of the national pension sche...
New government wants to stabilize conventional structure of health ministry
Business sources said that the new appointments of Vice minister of Health and Welfare Kang Yoon-koo and Commissioner of Korea Food and Drug Administration Shim Chang-koo reflected the new government's aim to stabiliz...
First field inspection on bulk drug manufacturer.
The KFDA earlier adopted so called "Bulk Drug Report" system in July last year, applying to all bulk drugs, and under this program the KFDA is going to take a field inspection for the first time over a bulk drug manuf...
Korea's local vaccines export in 2002 topped $45 million
The Korea Food and Drug Administration said that Korea exported $45 million worth of its locally produced vaccines exported in 2002 to many countries (Mexcio, Brazil, Argentina, Vietnam, Pakistan, Sri Lanka, and Afric...
Government urged to grease R&D investment wheels
Business sources say that to better enhance R&D capability in the domestic pharmaceutical industry, the current reimbursement price criteria needs to be readjusted in a manner such that new R&D fund including the intr...
Company of more than one employee turned to Employee Insurance Category.
Effective from coming July the national health insurance system will remarkably changed to an effect that the company employee insurance encompasses all the small private company having even one employee according to ...
Industry complaining government's subsidy cut off for new drug R&D.
The pharmaceutical industry sensitively concerned about the government budgeting plans for the new drug R&D subsidy to skip. The MOHW budget amounting to the total 89,200 million won for the first half of 2003 did not...
Antidepressant market getting overheated
With the incessant new antidepressants launch, many foreign-invested firms have expanded their presence in the domestic antidepressants market, according to business sources.
The market scale for antidepressants la...
MSD to reduce the price of Zocor 40mg tablet by 1,200 won
MSD Korea said that it will reduce the current price of Zocor (simvastatin) 40mg, antihyperlipidemic, to 1,800 won per tablet from 1,200 won through its price readjustment application to the Health Insurance Review Ag...
